Research ArticleAccepted Article
Open Access
The Rheumatologist’s Role in Covid-19
Randy Q. Cron and W. Winn Chatham
The Journal of Rheumatology March 2020, jrheum.200334; DOI: https://doi.org/10.3899/jrheum.200334
Randy Q. Cron
From the Department of Pediatrics, Division of Rheumatology (RQC) and the Department of Medicine, Division of Clinical Immunology and Rheumatology (WWC), University of Alabama at Birmingham. Dr. Cron serves as a consultant to Novartis, Pfizer, and SOBI. Dr. Chatham has served as a consultant to Novartis and SOBI. Drs. Cron and Chatham are co-Principal Investigators on an investigator initiated clinical trial to study interleukin-1 blockade in treating secondary hemophagocytic lymphohistiocytosis in children and adults that is funded by Swedish Orphan Biovitrum, Inc. (SOBI) []. Address correspondence to Randy Q. Cron, MD, PhD, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, suite G10, Birmingham, AL 35233-1711. E-mail: rcron@peds.uab.edu.
W. Winn Chatham
From the Department of Pediatrics, Division of Rheumatology (RQC) and the Department of Medicine, Division of Clinical Immunology and Rheumatology (WWC), University of Alabama at Birmingham. Dr. Cron serves as a consultant to Novartis, Pfizer, and SOBI. Dr. Chatham has served as a consultant to Novartis and SOBI. Drs. Cron and Chatham are co-Principal Investigators on an investigator initiated clinical trial to study interleukin-1 blockade in treating secondary hemophagocytic lymphohistiocytosis in children and adults that is funded by Swedish Orphan Biovitrum, Inc. (SOBI) []. Address correspondence to Randy Q. Cron, MD, PhD, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, suite G10, Birmingham, AL 35233-1711. E-mail: rcron@peds.uab.edu.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
The Rheumatologist’s Role in Covid-19
Randy Q. Cron, W. Winn Chatham
The Journal of Rheumatology Mar 2020, jrheum.200334; DOI: 10.3899/jrheum.200334